Position in NTRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$395,231
New position
Shares Held
1,456
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#569
of 844 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026MONETA GROUP INVESTMENT ADVISORS LLC holds $33,351,553 across 12 Diagnostics & Research names. NTRA ranks #7 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
120,316 | $22,917,791 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
8,360 | $4,191,369 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
4,904 | $2,581,661 | |
| 4 | RVTY |
Revvity, Inc.
|
6,819 | $758,681 | |
| 5 | LH |
Labcorp Holdings Inc.
|
1,732 | $484,960 | |
| 6 | A |
Agilent Technologies, Inc.
|
2,983 | $396,231 | |
| 7 | NTRA |
Natera, Inc.
This page
|
1,456 | $395,231 | |
| 8 | GRAL |
GRAIL, Inc.
|
5,644 | $385,315 |
All Filings in NTRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $395,231 | 1,456 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||